Change in the Management of TSS

The TSS company logo, representing a change in the company's management.
Document

We are thrilled to announce a new chapter at TSS as we bid farewell to our esteemed CEO, Niclas Ohlsson.
3 July 2024

What is on this page?

Click to jump to a specific section below.

Introduction

Our whole story starts here

Mission and vision

After 16 years of dedicated service as our Chief Executive Officer (CEO), Niclas Ohlsson has made the decision to step down to prioritize his well-being following a recent health scare. Niclas has been instrumental in shaping TSS into a leading company within the industry, and we are truly grateful for his years of hard work and leadership.

Stepping into the role of CEO is Tobias Holmer, our CTO for the past 9 years and interim CEO for the last 7 months. Tobias's wealth of experience and forward-thinking leadership have already positively impacted our organization, and we are enthusiastic about the exciting future under his guidance.

We are excited to continue our mission of delivering the highest standards in temperature monitoring solutions for the pharmaceutical industry.

Join us in wishing Niclas all the best in his future endeavors and thanking him for his remarkable contributions. Here’s to a new era of growth and success with Tobias at the helm!

__wf_reserved_inherit
Tobias Holmer, CEO

You may also be interested in

Can You Rely on the Results from Your Clinical Trials?

The success of a clinical trial depends on the reliability of its data. Many investigational drugs are sensitive to temperature, and any temperature deviation can affect their quality and, in the worst case, patient safety. Automated and integrated temperature monitoring solutions help secure data quality, support compliance, and speed up the delivery of new medicines to patients.
Read moreDownload Whitepaper
A collage illustrating three steps for clinical trials: vaccine vials, data analysis, and a healthcare professional.

3 steps to accelerate Decentralized trials & Release to patients

Seamless monitoring of direct-to-patient shipments within an end-to-end calculation engine enables a digital release in patient's homes. Site centric technology also allows for a decentralized and proactive approach, reducing waste. Furthermore, digitalizing temperature management end-to-end enables a faster release of products for all types of trials and creates a foundation for successful decentralized drives.
Read moreDownload Whitepaper
The EcoVadis Silver 2023 Sustainability Rating medal next to hands holding planet Earth, symbolizing TSS's achievement.

TSS Achieves EcoVadis Silver Medal for Advanced Sustainability Performance

TSS, a leading Swedish Software-as-a-Service (SaaS) company specializing in automated temperature monitoring solutions, is thrilled to announce that it has been awarded the prestigious EcoVadis Silver Medal for its advanced sustainability performance. With an overall score of 65, TSS has secured its position among the top 13% of sustainable world-leading companies, firmly establishing itself as a trailblazer in the industry.
Read moreDownload Whitepaper

You may also be interested in

Meet Us at GCSG 2026 in Rome

TSS will be joining the GCSG 2026 European Knowledge Forum, taking place October 13–15 in Rome, Italy.
Read more

What Do EMA’s Updated Shortage Prevention Guidelines Mean for Pharmaceutical Leaders?

The European Medicines Agency has updated its guidance and template for Shortage Prevention Plans. For pharmaceutical leaders, the development is more than a regulatory planning exercise. It is an invitation to examine whether their organizations can identify supply vulnerabilities early and respond before an issue affects medicine availability.
Read more

Subscribe to our newsletter

Sign up for our newsletter to receive all the latest TSS news and insights in temperature management solutions.